0000876661-15-000047.txt : 20150130
0000876661-15-000047.hdr.sgml : 20150130
20150130162724
ACCESSION NUMBER: 0000876661-15-000047
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20150130
DATE AS OF CHANGE: 20150130
EFFECTIVENESS DATE: 20150130
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Covidien plc
CENTRAL INDEX KEY: 0001385187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980624794
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33259
FILM NUMBER: 15563409
BUSINESS ADDRESS:
STREET 1: 20 ON HATCH
STREET 2: LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: DUBLIN 2
BUSINESS PHONE: 353 1 438-1700
MAIL ADDRESS:
STREET 1: 20 ON HATCH
STREET 2: LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: DUBLIN 2
FORMER COMPANY:
FORMER CONFORMED NAME: Covidien Ltd.
DATE OF NAME CHANGE: 20070321
FORMER COMPANY:
FORMER CONFORMED NAME: Tyco Healthcare Ltd.
DATE OF NAME CHANGE: 20070104
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
1385187
Covidien plc
001-33259
15 Hampshire Street
Cabot Industrial Park, Building 4
Mansfield
MA
MASSACHUSETTS
02048
(508) 261-8000
Ordinary Shares
17 CFR 240.12d2-2(a)(3)
Paras Madho
Director
2015-01-30
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on February 10, 2015, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on January 26, 2015 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.
The merger between Covidien plc and Medtronic, Inc. became effective on January 26, 2015. Each Covidien plc Ordinary Share was exchanged for $35.19 in cash and 0.956 of a (New) Ordinary Shares of Medtronic plc.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on January 27, 2015.